Back

Electrophysiological characteristics and durability of index pulsed field ablation lesions from redo procedures for atrial arrhythmia recurrences.

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 8 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Masaaki Yokoyama

Hospital Haut Leveque, Bordeaux (France)

6 More presentations in this session

Presentation thumbnail
Charge-density mapping to evaluate non-pulmonary vein substrate in patients with paroxysmal atrial fibrillation: the ACUPRED study
Doctor L. Pannone (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Identifying patients with reduced risk of recurrences after ablation for persistent atrial fibrillation
Doctor L. Riis-Vestergaard (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Evaluation of the cavotricuspid isthmus contractile kinetics within an interventional CMR environment
Miss A. Pusterle De Cidrac (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Evaluating left atrial wall thickness: a new frontier in predicting atrial scar and reentrant tachycardia
Doctor C. Coteli (Ankara, TR) Doctor S. Kilic (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Electrophysiological findings, incidence, and predictors for AF recurrence after pulsed field versus radiofrequency pulmonary vein isolation. A retrospective analysis.
Doctor A. Eberl (Graz, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 8 - ablation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Findings at repeat ablation after complex left atrial pulsed field ablation for longstanding persistent atrial fibrillation
thumbnail
Congress Presentation
Is pulsed field ablation a valide alternative to radiofrequency in redo ablations? a prospective, multicenter experience.
thumbnail
Congress Presentation
Feasibility and efficacy of single-shot PFA technology for redo procedures after a previous atrial fibrillation ablation procedure.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources